HCPLive.com
HCPLive Podcasts
Your destination feed for medical, health care and clinical science podcasts courtesy of HCPLive—featuring our shows Medical Ethics Unpacked, New Insight, and 5 Stories in Under 5.
Be sure to visit the podcast's website and support the creator: www.hcplive.com
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Advances in Pediatric Eczema Highlight 2022 21.12.2022 21:35
Lawrence Eichenfield, MD, reviews major drug approvals and advancement of screening and prevention strategies for the youngest patients with atopic dermatitis.
What Ruxolitinib Cream Meant For Dermatology in 2022 20.12.2022 13:18
As 2022 concludes, a dermatologist reflects on the first drug approved for vitiligo.
A Geographic Atrophy Treatment Breakthrough with David R. Lally, MD 10.11.2022 18:47
Dr. Lally of New England Retina Consultants joins to discuss avacincaptad pegol, a promising injection treatment for GA, and its supporting data from the GATHER trial program. Will the complement C5 inhibitor drug receive FDA approval in 2023? Lally discusses this and more on the latest DocTalk.
ACR 22 Convergence Preview, with Dr. McMahan 07.11.2022 13:04
Ahead of the American College of Rheumatology 2022 Convergence meeting on Nov. 10-14, our editorial team sat down with planning committee member Zsuzsanna McMahan, MD, MHS, of Johns Hopkins University School of Medicine, to take a deep dive into the upcoming meeting.
Rare Disease Report: The FDA Decision for Pompe Disease Therapy 28.10.2022 13:25
The FDA is expected to announce the final decision for the dual therapy AT-GAA, which uses miglustat in combination with cipaglucosidase alfa for treating Pompe disease, an inherited and often times fatal disorder. Expert Barry Byrne discusses the characteristics of the condition and what this FDA decision will mean for treatment.
Arshad Khanani, MD: A Breakthrough in Geographic Atrophy Treatment 14.10.2022 12:30
One of the most notable topics discussed at the 2022 American Academy of Ophthalmology Meeting in Chicago was new advancements in geographic atrophy (GA) treatment. A form of advanced age-related macular degeneration (AMD), there are no currently available treatments for the debilitating disease. In this episode of DocTalk , we spoke with Arshad Khanani, MD, Director of Clinical Research, Sierra E...
Rare Disease Report: Newborn Screening Awareness & Novel Diagnostic Tool 10.10.2022 20:46
In the wake of Newborn Screening Awareness Month, this episode dives into a novel diagnostic precision medicine guidance tool called BeginNGS. Catherine Nester, RN, and Dr. Stephen Kingsmore, discuss the pivotal role of newborn screening in diagnosing rare diseases. As representatives from collaborating partners Inozyme Pharma and Rady Children's Institute that created this tool, they explain the...
Heart Team: Making Ground on Women's Cardiovascular Health with Martha Gulati, MD 05.10.2022 23:31
Martha Gulati, MD, Director of Preventive Cardiology, Associate Director of the Barbara Streisand Women’s Heart Center, Associate Director of Preventive and Cardiac Rehabilitation at Cedars-Sinai Medical Center, joins Heart Team to discuss current challenges in women’s cardiovascular disease research and clinical advancement. Gulati also provides guidance on improving female trial enrollment strat...
Heart Team: Cardiology & Nephrology Collaborations with Dr. Matthew Weir 06.09.2022 31:14
In the first episode from this new cardiovascular medicine series, hosts Dr. Jorge Plutzky and Dr. Michael Farkouh speak with University of Maryland's Dr. Matthew Weir about the growing involvement of renal care in modern heart disease patients.
Rare Disease Report: CDKL5 Deficiency Disorder Expert Interview 02.09.2022 19:05
The second episode of the 2-part Rare Disease Report shifts to a clinical perspective with the expertise of Dr. Pestana, a pediatric epileptologist at the Epilepsy Center, Cleveland Clinic Neurological Institute who treats patients with CDKL5 deficiency disorder (CDD).
Rare Disease Report: CDKL5 Deficiency Disorder 31.08.2022 23:51
In the first episode of a 2-part Rare Disease Report, Whitney Mitchell, mother and caregiver to her 6 year old daughter Havilah, shared her experience leading up to, and now living with, Havilah’s CDKL5 deficiency disorder (CDD) diagnosis.
The Biggest Discussions in Retina from the 2022 ASRS Annual Meeting 20.07.2022 13:46
This past week, the American Society of Retina Specialists (ASRS) held its 40th Annual Meeting in New York City to discuss landmark data and the newest advancements in retina care. The HCPLive team was on-site at the Javits Center in Manhattan conducting interviews with expert retina specialists on topics including drugs for neovascular age-related macular degeneration and geographic atrophy, as...
FDA Approves Ruxolitinib: New Horizons in Vitiligo Care 20.07.2022 8:13
On Monday, the US Food and Drug Administration (FDA) approved ruxolitinib cream 1.5% for the treatment of nonsegmental vitiligo in adults and pediatric patients 12 years and older, making it both the first FDA-approved therapy for repigmentation and the only topical formulation of a JAK inhibitor approved in the United States. The groundbreaking approval was supported by phase 3 data from the TRue...
How Pegloticase Plus Methotrexate is Breaking Ground in Gout Care 12.07.2022 15:57
Last week, the US Food and Drug Administration (FDA) approved the co-treatment of pegloticase (Krystexxa) injection plus methotrexate (MTX) for uncontrolled gout, a decision bolstered by data from phase 4 of the MIRROR study. In that study, 71% of patients who were treated with this combination therapy achieved a complete response over the course of 6 months. Comparatively, only 38.5% of patients...
What Ustekinumab Provides in Long-Term IBD Care 29.06.2022 14:15
Despite a bevy of biologics available for people struggling with Crohn’s disease and ulcerative colitis (UC), not all patients are able to respond to or tolerate a vast majority of approved therapies. Fortunately, new data presented at Digestive Disease Week (DDW) 2022 suggests that ustekinumab (STELARA) could function as an alternative option to bio-failure and bio-naïve patients living with thes...
Exploring New Horizons in Ophthalmology Care with Gene Therapy 27.06.2022 9:13
If you’ve been keeping an eye on recent developments in ophthalmic care, then you’ll know that several new therapeutic agents that had been approved by the US Food and Drug Administration (FDA) in recent months, including ranibizumab delivered via Port Delivery System (PDS) and faricimab , the latter of which became the first-of-its-kind intravitreal bispecific biologic therapy for both age-relate...
How the Newest Dupilumab Approval Solves an "Unmet Need" in Children with AD 20.06.2022 17:14
Earlier this month, dupilumab became the first and only biologic medicine approved by the US Food and Drug Administration for the treatment of atopic dermatitis in patients of all ages, from infancy through adulthood. The approval of dupilumab as an add-on maintenance therapy for children 6 months to 5 years with moderate to severe atopic dermatitis was described as “a tremendous advancement” by M...
Dermatologists Discuss the FDA Approval of Baricitinib for Alopecia Areata 16.06.2022 22:38
On June 13, the US Food and Drug Administration (FDA) approved oral baricitinib (Olumiant) tablets for the treatment of severe alopecia areata in adults, which marked the first approval of a systemic treatment for the disorder. The approval has excited patients and providers alike who struggled for decades to treat severe cases of this autoimmune disorder. For this episode of DocTalk , several key...
Dermatologists Discuss the FDA Approval of Baricitinib for Alopecia Areata 16.06.2022 22:09
On June 13, the US Food and Drug Administration (FDA) approved oral baricitinib (Olumiant) tablets for the treatment of severe alopecia areata in adults, which marked the first approval of a systemic treatment for the disorder. The approval has excited patients and providers alike who struggled for decades to treat severe cases of this autoimmune disorder. For this episode of DocTalk, several key...
Sleeping Through Infectious Disease and the COVID-19 Vaccine 14.06.2022 21:56
After presenting at the SLEEP 2022 annual meeting, Dr. Aric Prather explains the findings of his previous research demonstrated lack of sleep (6 hours or less) was associated with a 4 times higher risk of becoming sick after exposure to rhinovirus in an interview with HCPLive . Currently, Prather and his team at UCSF are working with a large naive population for a study that began in March 2021. T...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.